These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22357376)

  • 1. Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient.
    Rais M; Cahn W; Schnack HG; Hulshoff Pol HE; Kahn RS; van Haren NE
    Psychol Med; 2012 Sep; 42(9):1847-56. PubMed ID: 22357376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study.
    Antonova E; Kumari V; Morris R; Halari R; Anilkumar A; Mehrotra R; Sharma T
    Biol Psychiatry; 2005 Sep; 58(6):457-67. PubMed ID: 16039619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia.
    Brans RG; van Haren NE; van Baal GC; Schnack HG; Kahn RS; Hulshoff Pol HE
    Arch Gen Psychiatry; 2008 Nov; 65(11):1259-68. PubMed ID: 18981337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grey matter abnormalities in first-episode schizophrenia and affective psychosis.
    Morgan KD; Dazzan P; Orr KG; Hutchinson G; Chitnis X; Suckling J; Lythgoe D; Pollock SJ; Rossell S; Shapleske J; Fearon P; Morgan C; David A; McGuire PK; Jones PB; Leff J; Murray RM
    Br J Psychiatry Suppl; 2007 Dec; 51():s111-6. PubMed ID: 18055926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of IQ Changes and Progressive Brain Changes in Patients With Schizophrenia.
    Kubota M; van Haren NE; Haijma SV; Schnack HG; Cahn W; Hulshoff Pol HE; Kahn RS
    JAMA Psychiatry; 2015 Aug; 72(8):803-12. PubMed ID: 26083394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prefrontal but not temporal grey matter changes in males with first-episode schizophrenia.
    Kaspárek T; Prikryl R; Mikl M; Schwarz D; Cesková E; Krupa P
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):151-7. PubMed ID: 17011096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insular cortex abnormalities in schizophrenia: Relationship to symptoms and typical neuroleptic exposure.
    Pressler M; Nopoulos P; Ho BC; Andreasen NC
    Biol Psychiatry; 2005 Feb; 57(4):394-8. PubMed ID: 15705355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia.
    Boonstra G; van Haren NE; Schnack HG; Cahn W; Burger H; Boersma M; de Kroon B; Grobbee DE; Hulshoff Pol HE; Kahn RS
    J Clin Psychopharmacol; 2011 Apr; 31(2):146-53. PubMed ID: 21346618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities.
    Davatzikos C; Shen D; Gur RC; Wu X; Liu D; Fan Y; Hughett P; Turetsky BI; Gur RE
    Arch Gen Psychiatry; 2005 Nov; 62(11):1218-27. PubMed ID: 16275809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
    McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
    Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia.
    Rais M; van Haren NE; Cahn W; Schnack HG; Lepage C; Collins L; Evans AC; Hulshoff Pol HE; Kahn RS
    Eur Neuropsychopharmacol; 2010 Dec; 20(12):855-65. PubMed ID: 20863671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study.
    Yamasue H; Iwanami A; Hirayasu Y; Yamada H; Abe O; Kuroki N; Fukuda R; Tsujii K; Aoki S; Ohtomo K; Kato N; Kasai K
    Psychiatry Res; 2004 Sep; 131(3):195-207. PubMed ID: 15465289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the neuropsychological and neuroanatomical changes that occur over the first 2-3 years of illness in patients with first-episode schizophrenia.
    Zipparo L; Whitford TJ; Redoblado Hodge MA; Lucas S; Farrow TF; Brennan J; Gomes L; Williams LM; Harris AW
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):531-8. PubMed ID: 18061326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impulsivity-related brain volume deficits in schizophrenia-addiction comorbidity.
    Schiffer B; Müller BW; Scherbaum N; Forsting M; Wiltfang J; Leygraf N; Gizewski ER
    Brain; 2010 Oct; 133(10):3093-103. PubMed ID: 20647266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.
    Witthaus H; Kaufmann C; Bohner G; Ozgürdal S; Gudlowski Y; Gallinat J; Ruhrmann S; Brüne M; Heinz A; Klingebiel R; Juckel G
    Psychiatry Res; 2009 Sep; 173(3):163-9. PubMed ID: 19616415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis.
    Suzuki M; Zhou SY; Takahashi T; Hagino H; Kawasaki Y; Niu L; Matsui M; Seto H; Kurachi M
    Brain; 2005 Sep; 128(Pt 9):2109-22. PubMed ID: 15930048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.
    Ho BC; Andreasen NC; Nopoulos P; Arndt S; Magnotta V; Flaum M
    Arch Gen Psychiatry; 2003 Jun; 60(6):585-94. PubMed ID: 12796222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between volumetric brain changes and cognitive function: a family study on schizophrenia.
    Toulopoulou T; Grech A; Morris RG; Schulze K; McDonald C; Chapple B; Rabe-Hesketh S; Murray RM
    Biol Psychiatry; 2004 Sep; 56(6):447-53. PubMed ID: 15364043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mr morphometry analysis of grey matter volume reduction in schizophrenia: association with hallucinations.
    Neckelmann G; Specht K; Lund A; Ersland L; Smievoll AI; Neckelmann D; Hugdahl K
    Int J Neurosci; 2006 Jan; 116(1):9-23. PubMed ID: 16318996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.